Biomarker Testing May Transform Treatment Of Acute Gvhd

Biomarker testing may transform treatment of acute GVHD (Part 1)

MDedge: news and insights for busy physicians

Biomarker testing may transform treatment of acute GVHD (Part 2)

MDedge: news and insights for busy physicians

Amphiregulin as a monitoring biomarker during treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Transforming GVHD Treatment: The Mount Sinai Acute GVHD International Consortium (MAGIC)

Icahn School of Medicine

What is the latest update on biomarkers for assessing GvHD?

Key biomarkers in the management of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Acute GVHD: Biomarkers and Biology

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Icahn School of Medicine

How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes

MDedge: news and insights for busy physicians

Precision BMT Through Biomarkers

Icahn School of Medicine

Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?

Managed Healthcare Executive

Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease

PeerView Oncology

The microbiota as a biomarker for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

GvHD highlights: use of biomarkers to guide treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment

Managed Healthcare Executive

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology

Biomarkers for Graft-Versus-Host Disease: Biomarkers as Companion Diagnostics

Managed Healthcare Executive

From Biomarker Testing to Treatment: Precision Medicine for Solid Tumors (Genomic Testing)

Cancer Support Community

GvHD biomarker discovery and validation

VJHemOnc – Video Journal of Hematology & HemOnc

What are the current treatment recommendations for acute GvHD and the promotion of the GvL effect?